These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28985171)

  • 1. Which patients with respiratory disease need long-term azithromycin?
    Alchakaki A; Cramer C; Patterson A; Soubani AO
    Cleve Clin J Med; 2017 Oct; 84(10):755-758. PubMed ID: 28985171
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.
    Smith D; Du Rand I; Addy CL; Collyns T; Hart SP; Mitchelmore PJ; Rahman NM; Saggu R
    Thorax; 2020 May; 75(5):370-404. PubMed ID: 32303621
    [No Abstract]   [Full Text] [Related]  

  • 5. Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
    Brusselle GG
    Thorax; 2015 May; 70(5):401-3. PubMed ID: 25870311
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
    Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly.
    Taylor SP; Sellers E; Taylor BT
    Am J Med; 2015 Dec; 128(12):1362.e1-6. PubMed ID: 26291905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections].
    Alvarez MP; Simón M; Sánchez S; Apaloaza I; Prieto J
    Rev Esp Quimioter; 2000 Sep; 13(3):297-305. PubMed ID: 11086281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.
    Tsuji BT; Fisher J; Boadi-Yeboah R; Holden PN; Sethi S; Pettigrew MM; Murphy TF
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potentially misdiagnosed suppurative and obstructive airway disease.
    Tirpude S; Karkhanis V; Joshi JM
    J Postgrad Med; 2012; 58(4):302-4. PubMed ID: 23298930
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
    Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
    Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study.
    Khalid M; Al Saghir A; Saleemi S; Al Dammas S; Zeitouni M; Al Mobeireek A; Chaudhry N; Sahovic E
    Eur Respir J; 2005 Mar; 25(3):490-3. PubMed ID: 15738293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of herpes simplex keratitis after azithromycin.
    Kumar S
    Indian J Ophthalmol; 2007; 55(1):84-5. PubMed ID: 17189905
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of herpes simplex keratitis after azithromycin.
    Pai VH
    Indian J Ophthalmol; 2007; 55(4):320-1; author reply 321. PubMed ID: 17595492
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet?
    Restrepo MI; Anzueto A
    Am J Respir Crit Care Med; 2014 Jul; 190(1):1-2. PubMed ID: 24983214
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections.
    Treadway G; Pontani D; Reisman A
    Int J Antimicrob Agents; 2002 Mar; 19(3):189-94. PubMed ID: 11932140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azithromycin as a novel treatment for bronchiolitis obliterans syndrome].
    Peled N; Shitrit D; Bendayan D; Kramer MR
    Harefuah; 2007 Mar; 146(3):219-22, 245. PubMed ID: 17460931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.